241 related articles for article (PubMed ID: 25505887)
21. Bioequivalence of fixed dose combination of atorvastatin 10 mg and aspirin 150 mg capsules: a randomized, open-label, single-dose, two-way crossover study in healthy human subjects.
Tippabhotla SK; Betha MR; Gadiko C; Battula R; Nakkawar M; Cheerla R; Khan SM; Yergude S; Thota S; Vobalaboina V
Drug Res (Stuttg); 2013 May; 63(5):250-7. PubMed ID: 23526241
[TBL] [Abstract][Full Text] [Related]
22. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
23. Investigation of the discriminatory ability of analytes for the bioequivalence assessment of ezetimibe: Parent drug, metabolite, total form, and combination of parent drug and total form.
Hsieh CM; Hsu LF
Eur J Pharm Sci; 2022 Jul; 174():106192. PubMed ID: 35439544
[TBL] [Abstract][Full Text] [Related]
24. Ezetimibe: new preparation. A cholesterol-lowering drug with no clinical advantage.
Prescrire Int; 2004 Oct; 13(73):176-9. PubMed ID: 15499698
[TBL] [Abstract][Full Text] [Related]
25. Impact of Atorvastatin Combined with Ezetimibe for the Treatment of Carotid Atherosclerosis in Patients with Coronary Heart Disease.
Luo P; Wang L; Zhu H; Du S; Wang G; Ding S
Acta Cardiol Sin; 2016 Sep; 32(5):578-585. PubMed ID: 27713607
[TBL] [Abstract][Full Text] [Related]
26. Interaction of single-dose ezetimibe and steady-state cyclosporine in renal transplant patients.
Bergman AJ; Burke J; Larson P; Johnson-Levonas AO; Reyderman L; Statkevich P; Maxwell SE; Kosoglou T; Murphy G; Gottesdiener K; Robson R; Paolini JF
J Clin Pharmacol; 2006 Mar; 46(3):328-36. PubMed ID: 16490809
[TBL] [Abstract][Full Text] [Related]
27. Fixed-dose combination ezetimibe+atorvastatin lowers LDL-C equivalent to co-administered components in randomized trials: use of a dose-response model.
Bays HE; Chen E; Tomassini JE; McPeters G; Polis AB; Triscari J
Fundam Clin Pharmacol; 2015 Apr; 29(2):209-18. PubMed ID: 25431239
[TBL] [Abstract][Full Text] [Related]
28. Co-Amorphous Formation of Simvastatin-Ezetimibe: Enhanced Physical Stability, Bioavailability and Cholesterol-Lowering Effects in LDLr-/-Mice.
Bahetibieke S; Moinuddin SM; Baiyisaiti A; Liu X; Zhang J; Liu G; Shi Q; Peng A; Tao J; Di C; Cai T; Qi R
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745830
[TBL] [Abstract][Full Text] [Related]
29. LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD.
McKenney J; Ballantyne CM; Feldman TA; Brady WE; Shah A; Davies MJ; Palmisano J; Mitchel YB
MedGenMed; 2005 Jul; 7(3):3. PubMed ID: 16369229
[TBL] [Abstract][Full Text] [Related]
30. Pharmacodynamic interaction between ezetimibe and rosuvastatin.
Kosoglou T; Statkevich P; Yang B; Suresh R; Zhu Y; Boutros T; Maxwell SE; Tiessen R; Cutler DL
Curr Med Res Opin; 2004 Aug; 20(8):1185-95. PubMed ID: 15324521
[TBL] [Abstract][Full Text] [Related]
31. Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia.
Farnier M; Guyton JR; Jensen E; Polis AB; Johnson-Levonas AO; Brudi P
Atherosclerosis; 2013 Aug; 229(2):415-22. PubMed ID: 23880197
[TBL] [Abstract][Full Text] [Related]
32. Effects of ezetimibe on cyclosporine pharmacokinetics in healthy subjects.
Bergman AJ; Burke J; Larson P; Johnson-Levonas AO; Reyderman L; Statkevich P; Kosoglou T; Greenberg HE; Kraft WK; Frick G; Murphy G; Gottesdiener K; Paolini JF
J Clin Pharmacol; 2006 Mar; 46(3):321-7. PubMed ID: 16490808
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia.
Gagné C; Gaudet D; Bruckert E;
Circulation; 2002 May; 105(21):2469-75. PubMed ID: 12034651
[TBL] [Abstract][Full Text] [Related]
34. Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapy.
Toth PP; Bays HE; Brown WV; Catapano AL; Davidson MH; Farnier M; Tomassini JE; Jensen E; Polis AB; Tershakovec AM
J Clin Lipidol; 2019; 13(6):997-1007.e8. PubMed ID: 31629703
[TBL] [Abstract][Full Text] [Related]
35. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
[TBL] [Abstract][Full Text] [Related]
36. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?
Piorkowski M; Fischer S; Stellbaum C; Jaster M; Martus P; Morguet AJ; Schultheiss HP; Rauch U
J Am Coll Cardiol; 2007 Mar; 49(10):1035-42. PubMed ID: 17349882
[TBL] [Abstract][Full Text] [Related]
37. Assessment of a multiple-dose drug interaction between ezetimibe, a novel selective cholesterol absorption inhibitor and gemfibrozil.
Reyderman L; Kosoglou T; Statkevich P; Pember L; Boutros T; Maxwell SE; Affrime M; Batra V
Int J Clin Pharmacol Ther; 2004 Sep; 42(9):512-8. PubMed ID: 15487810
[TBL] [Abstract][Full Text] [Related]
38. Development of a sustainable multianalyte MEKC method for quantitation of the antihyperlipidemic drugs ezetimibe together with three statins. Greenness and whiteness appraisal studies.
Elbordiny HS; Elonsy SM; Daabees HG; Belal TS
BMC Chem; 2023 Sep; 17(1):124. PubMed ID: 37742031
[TBL] [Abstract][Full Text] [Related]
39. Ezetimibe: a first-in-class, novel cholesterol absorption inhibitor.
Lipka LJ
Cardiovasc Drug Rev; 2003; 21(4):293-312. PubMed ID: 14647533
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
